Research

Omega 3 fatty acids

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Indication: Heart failure



Source: European Journals of Heart Failure 2009 11(10):922-928.

Research: Evidence is accumulating for a cardioprotective effect of fish or its n-3 fatty acids EPA and DHA. Researchers examined EPA and DHA and fish intake in relation to incident heart failure in the population-based Rotterdam Study.

Results: Analysis comprised 5299 subjects (41% men, age about 68 years, free from heart failure) for whom dietary data were available. During 11.4 years of follow-up 669 subjects developed heart failure. The relative risk (RR) of heart failure in the top vs. bottom quintile of EPA and DHA intake was 0.89 (95% CI 0.69-1.14) after adjustment for lifestyle and dietary factors. For fish intakes >29 grams/day, the RR was 0.96 (.78-1.18) compared with no fish intake. In sex-specific analysis, a high EPA and DHA intake tended to be protective in women (RR=0.75, 0.54-1.04) but not in men (RR=1.00, 0.73-1.36). An inverse association for EPA and DHA was also observed in diabetics (RR=0.58, 0.32-1.06), which was borderline statistically significant. Researchers indicate that findings do not support a major role for fish intake in the prevention of heart failure. The potentially protective effect of EPA and DHA in diabetic patients, however, warrants further investigation.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters